Avadel pharmaceuticals to provide a corporate update and preliminary fourth quarter and full year 2024 financial highlights on january 8

Dublin, jan. 03, 2025 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 4:30 p.m. et on wednesday, january 8, 2025, to provide a corporate update and discuss the company's preliminary unaudited financial results for the fourth quarter and full year ended december 31, 2024.
AVDL Ratings Summary
AVDL Quant Ranking